More
    Guided Solutions - Connecting Talent With Innovation/div>

    Venus Medtech announces first implant of VenusP-Valve system in study

    Venus Medtech has announced completion of the first implantation of its VenusP-Valve system in the US as part of the PROTEUS investigational device exemption...

    Askel presented first clinical trial results of its COPLA® knee cartilage implant at the 9th Joint Preservation Congress in Warsaw, Poland on June 14-15,...

    Askel Healthcare, a Finnish medical technology company pioneering the treatment and repair of focal knee cartilage defects, presented results from its first-in-human Pilot Clinical...

    Foldax reveals positive results from TRIA heart valve trial

    Utah-based heart valve firm, Foldax has reported favorable early safety results in a trial of its TRIA mitral surgical heart valve designed using a...

    Sequel Med Tech study backs its automated insulin pump

    A study looking at automated insulin delivery technology from Sequel Med Tech highlighted the ability to address delayed occlusion detection. According to Sequel, an...

    Stimvia reports positive results from PD treatment trial

    Medical technology company Stimvia has announced initial positive results from its pilot study for a new add-on treatment for patients with Parkinson’s disease (PD).The...

    Zeta Surgical sees positive results in guided neurosurgery trial

    Singapore-based surgical robotics and mixed reality firm, Zeta Surgical, has announced the completion of its first multi-centre clinical trial examining its Zeta cranial navigation...

    MiRus reports positive results from human trial of Siegel TAVR

    MiRus announced positive results from the first in-human trials of its MiRus Siegel transcatheter aortic heart valve (TAVR).The trial, involving five patients with severe...

    Caristo touts study showing accuracy of its CaRi-Heart technology

    Caristo has announced that a study demonstrating that its AI CaRi-Heart technology can predict cardiac events due to coronary inflammation at least ten years...

    Dopavision sees success from early-stage Myopia app trial

    German medical software company Dopavision has announced positive results from its MyopiaX-1 proof-of-concept clinical trial examining its smartphone app designed to advance the recovery...

    Latest articles